Vaccines

Scientists from The Scripps Research Institute and the La Jolla Institute for Allergy and Immunology may have found the best delivery mode for a vaccine against HIV.

Measles in Ontario, more endoscope-related infections, a study of postnatal Zika infections, research and development on a river blindness vaccine, and using CRISPR to tackle Zika are the articles that make up this week’s Top 5.

A team of researchers from several institutions have received a grant to fund the development of a vaccine for onchocerciasis, the second leading infectious cause of blindness.

A new report on a measles outbreak that occurred in Ontario in 2015 emphasizes the importance of immunization in a globalized world.

Pleuromutilin antibiotics, meningococcal disease, tuberculosis, a new fluoroquinolone to treat acute bacterial skin and skin structure infections, and WHO’s position on HPV vaccine recommendations makes up this week’s Top 5 articles.

WHO releases recommendations regarding HPV vaccination as primary preventive intervention against cervical cancer.

The CDC examines the high incidence of meningococcal disease in the “meningitis belt,” found within sub-Saharan Africa, and the efforts of the Meningitis Vaccine Project to monitor the impact of a meningococcal A conjugate vaccine.

A research team headed by Carl D’Angio, MD, a physician in the Department of Pediatrics at the University of Rochester Medical Center in Rochester, New York, compare flu vaccine response in PT versus FT infants.

In case you missed them, here are our top 5 articles for the week of May 21, 2017.

The key to meeting the Joint United Nations Program on HIV and AIDS (UNAIDS) benchmark may be to combine discrete areas of research into a more cohesive strategy.

Patricia Smith, President of the Lyme disease Association Inc., discusses Lyme disease infection prevention.

While the 2016 Ebola outbreak in the Democratic Republic of Congo continues to unfold, researchers have identified the first natural human antibodies against all three major disease-causing ebolaviruses.

Researchers from Beaumont hospital have developed a Zika virus diagnostic test that yields quick results. In addition, a Zika vaccine may be coming our way, but perhaps not in the way we hoped.

On HIV Vaccine Awareness Day, we reflect on the advancements made in the fight against HIV and the ongoing efforts to reach the collective goal of developing a safe, effective vaccine.

This week’s Public Health News Watch focuses on what’s potentially behind the recent outbreak of measles in a Somali community in Minnesota.

CDC researchers have found that an invasive serotype of Streptococcus pneumoniae belonging to nonvaccine serotype 35B has recently emerged.

As widespread and regional flu activity in the United States continues to dwindle, health officials are ready to say "goodbye" to flu season as they channel their efforts into preparing for the next one.

There are several diseases that pose a high risk in the dental healthcare setting; a review article highlights ones that are preventable by immunization.

In a recent webinar, the CDC and the HHS’s National Vaccine Program Office discussed global efforts being made to eradicate polio, measles, and rubella in the United States.

Health officials in Minnesota have linked the state’s biggest measles outbreak in decades to anti-vaccination efforts centered on one immigrant community.

In a collaborative effort, scientists from Johns Hopkins School of Medicine and George Washington University have found that defective HIV proviruses can complicate monitoring the true viral load within patients and distract the immune system from attacking the functional virus.

In case you missed them, here are our top 5 articles for the week of April 23, 2017.

Manufacturing issues have led to a shortage of the only yellow fever vaccine licensed in the United States; now, that shortage is expected to lead to a complete depletion of available vaccine by mid-2017.

The CDC offers insight into why a rare exception to the general recommendation of either brand of MenB vaccine had been made for the Rutgers outbreak in 2016.

On World Malaria Day, the world focuses on how to eliminate malaria once and for all.